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Fine motor control is achieved through the coordinated activation of groups of muscles, 
or “muscle synergies.” Muscle synergies change after stroke as a consequence of the 
motor deficit. We investigated the pattern and longitudinal changes in upper limb muscle 
synergies during therapy in a largely unconstrained movement in patients with a broad 
spectrum of poststroke residual voluntary motor capacity. Electromyography (EMG) was 
recorded using wireless telemetry from 6 muscles acting on the more-affected upper body 
in 24 stroke patients at early and late therapy during formal Wii-based Movement Therapy 
(WMT) sessions, and in a subset of 13 patients at 6-month follow-up. Patients were clas-
sified with low, moderate, or high motor-function. The Wii-baseball swing was analyzed 
using a non-negative matrix factorization (NMF) algorithm to extract muscle synergies from 
EMG recordings based on the temporal activation of each synergy and the contribution 
of each muscle to a synergy. Motor-function was clinically assessed immediately pre- and 
post-therapy and at 6-month follow-up using the Wolf Motor Function Test, upper limb 
motor Fugl-Meyer Assessment, and Motor Activity Log Quality of Movement scale. Clinical 
assessments and game performance demonstrated improved motor-function for all patients 
at post-therapy (p < 0.01), and these improvements were sustained at 6-month follow-up 
(p > 0.05). NMF analysis revealed fewer muscle synergies (mean ± SE) for patients with 
low motor-function (3.38 ± 0.2) than those with high motor-function (4.00 ± 0.3) at early 
therapy (p = 0.036) with an association trend between the number of synergies and the 
level of motor-function. By late therapy, there was no significant change between groups, 
although there was a pattern of increase for those with low motor-function over time. The 
variability accounted for demonstrated differences with motor-function level (p < 0.05) but 
not time. Cluster analysis of the pooled synergies highlighted the therapy-induced change 
in muscle activation. Muscle synergies could be identified for all patients during therapy 
activities. These results show less complexity and more co-activation in the muscle activa-
tion for patients with low motor-function as a higher number of muscle synergies reflects 
greater movement complexity and task-related phasic muscle activation. The increased 
number of synergies and changes within synergies by late-therapy suggests improved 
motor control and movement quality with more distinct phases of movement.
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inTrODUcTiOn
Fine motor control of the upper limb requires complex move-
ments based on multiple degrees of freedom that permit move-
ment variability and versatility (1, 2). The central nervous system 
controls such complex motor tasks by coordinated activation 
of groups of muscles, referred to as “muscle synergies” (3–6). 
The combination of the brain and spinal circuitry is essential 
for the simultaneous recruitment of multiple muscle synergies 
that explain a wide range of movement patterns (7, 8). Muscle 
synergies have been extracted from electromyography (EMG) 
recordings to define movements in both animals including frogs 
(9, 10), rats (11), cats (12–14), and monkeys (15); and humans 
with reference to gait (16–18), balance and posture (19, 20), hand 
function and posture (21, 22), arm movements (2, 7, 23), and 
isometric force (24, 25).
Multiple temporal synergy profiles are weighted and inte-
grated to define coordinated muscle activation during a task 
(2). Muscle synergies can include any number of muscles and 
each muscle can contribute to multiple synergies (8). Muscle 
synergies have been investigated in acute, subacute (26–28), 
and chronic stroke (17, 23, 29) showing abnormalities compared 
to healthy people (18, 30, 31). Such changes reflect poststroke 
motor impairment which can be attributed in large part to 
disorders in the neural pathway (8), reduced corticospinal drive 
(32), disuse atrophy (33), and loss of independent joint control 
and impaired motor coordination (29).
Muscle synergy analysis has detected poststroke abnormalities 
in the number, structure, and recruitment profile of muscle syner-
gies. For example, the number of muscle synergies recruited in 
the poststroke gait cycle was reduced in patients with more severe 
impairment and in comparison to healthy subjects (17, 34). This 
presumably reflects a change in the number of independent 
motor subtasks given the standard analysis of the gait cycle in four 
distinct phases and the use of four synergies for healthy subjects 
and patients with high motor-function.
Several analysis algorithms have been suggested for the 
decomposition of muscle activation profiles into muscle syner-
gies. Tresch and colleagues (35) evaluated and compared different 
matrix factorization methods including factor analysis, independ-
ent component analysis alone and applied to principle compo-
nent analysis, and non-negative matrix factorization (NMF). The 
authors concluded that these methods identify muscle synergies 
very similar to one another. In this study, we implemented NMF 
which has commonly been used to detect muscle synergies from 
EMG activation (17, 25, 36, 37). NMF quantifies muscle syner-
gies as a linear combination of the timing profile and a weighting 
assigned to each muscle involved in each synergy.
Few studies have examined the changes in poststroke muscle 
synergies with rehabilitation, but see Ref. (28). In this study, we 
extracted muscle synergies during a complex task to investigate 
the changes in muscle activation profiles (i.e., muscle synergies) 
in chronic stroke during an intensive 14-day protocol, in this case 
Wii-based Movement Therapy (WMT) (38, 39). This therapy is 
as effective as the current best practice in stroke rehabilitation, 
Constraint-induced Movement Therapy (38, 40). The primary 
aim of this study was not the therapy itself, but to quantify 
poststroke muscle synergies during therapy. Muscle synergy 
analysis cannot be used to investigate recovery mechanisms 
occurring in the brain but was used here as a neurophysiological 
indication to distinguish the level of impairment and the effect of 
therapy on coordinated muscle activation (41). To identify some 
of the neuromuscular mechanisms underpinning the improve-
ment reported using clinical motor-function assessments (38, 
39), NMF was applied to the EMG recorded from six muscles of 
the more-affected arm and upper body during the Wii-baseball 
component of WMT. This longitudinal study examined EMG at 
early and late therapy, and at 6-month follow-up for a subset of 
patients. We hypothesized that the number of muscle synergies 
would be correlated with the level of motor-function after stroke 
and that the number of synergies would change with therapy.
MaTerials anD MeThODs
Participants
Twenty four patients (16 males, 8 females) aged 37–80  years 
(57.9 ± 12.1, mean ± SD) and 3–88 months poststroke (26.7 ± 4.3, 
mean ±  SE) were randomly selected from a larger cohort who 
were consecutively recruited from St. Vincent’s and Prince of 
Wales’ Hospitals, Sydney [the same patients as presented in 
Hesam-Shariati et al. (42), see Table 1 for a summary of baseline 
characteristics]. All participants were hemiparetic following 
either an ischemic or hemorrhagic stroke and were classified into 
three groups of low, moderate, or high motor-function based on 
their ability to perform two tests of upper limb manual dexterity 
(43). The inclusion criteria were as before: ≥10° of voluntary 
movement in at least one digit of the more-affected hand; cogni-
tive competency measured as a Mini-Mental State Examination 
score ≥24; suitable skin for sensor placement; and the ability to 
communicate in English. Exclusion criteria included unstable 
blood pressure; comorbidities affecting upper limb sensorimotor 
function; and engagement in any other formal upper limb reha-
bilitation program. All participants gave signed informed consent 
to the study that was approved by the St. Vincent’s Hospital Human 
Research Ethics Committee, Sydney, and conducted in accord-
ance with the Declaration of Helsinki. Ten of the 24 patients could 
not attend the 6-month follow-up session for a range of reasons 
including: return to work, too far to travel, and unrelated health 
problems. The data for one patient were excluded for technical 
issues [see Ref. (42), Figure 1]. As detailed in Hesam-Shariati 
et al. (42), the clinical assessment results for all patients (but not 
NMF analyses) have been published previously [see Ref. (44) 
n = 20; (38) n = 9; and (40) n = 8].
Therapy
WMT is a standardized 14-day program focused on the more-
affected upper limb, which consists of 1-h of formal therapy on 
10 consecutive weekdays delivered by an Accredited Exercise 
Physiologist, augmented by prescribed home practice starting on 
day 2 and increasing throughout the program [see Figure 2A in 
Ref. (42)]. This therapy uses the Nintendo Wii and Wii-Sports 
games (Nintendo, Japan) as a rehabilitation tool that targets 
movement quality and independence in activities of daily living 
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(38, 39). The movements required in Wii-Sports were modified 
according to the capacity, range of motion, and strength of each 
patient. Although WMT games include Wii-golf, -baseball, -ten-
nis, -bowling, and -boxing, the analyses of this study were applied 
only to Wii-baseball swings. Each patient played two or three 
games of Wii-baseball during each session of therapy. This Wii-
baseball movement was selected for analysis for several reasons. 
First, all patients were able to complete this game, regardless of 
the level of residual voluntary motor-function. Second, the game 
determines the onset of each movement by pitching the ball. This 
allowed individual movements to be identified more clearly in the 
EMG signal. Finally, the nature of the game provided the most 
consistent task demands.
eMg recording
Surface EMG was recorded from six muscles of the upper body 
on the more-affected side: trapezius (middle portion), deltoid 
medius, biceps brachii (BB), extensor carpi radialis, flexor carpi 
radialis, and first dorsal interosseus (FDI) using Trigno wireless 
sensors (Delsys, USA). The data were collected continuously dur-
ing formal WMT sessions at early (day 2–3) and late (between 
days 12–14) therapy, and in a subset of patients, again during the 
6-month follow-up session. Each EMG sensor contains four silver 
bar electrodes, arranged in two pairs with an interelectrode pair 
distance of 10 mm. The sensor is designed to maximize the detec-
tion of muscle activation in a field perpendicular to the muscle 
fibers. Data were amplified 300 times, filtered between 20 and 
450 Hz, and sampled at 2 kHz using EMGworks (Delsys, USA) as 
per intrinsic device settings.
clinical Motor-Function assessments  
and game Performance
The efficacy of WMT was evaluated using clinical motor-func-
tion tests as described in Hesam-Shariati et  al. (42) including 
the Wolf Motor Function Test (WMFT) (45), upper limb motor 
Fugl-Meyer Assessment (FMA) (46), and the Motor Activity 
Log Quality of Movement scale (MALQOM) (47). The Wii-
baseball game performance was assessed as the number of hits, 
regardless of the outcome according to the rules of baseball, and 
this was recorded during therapy. However, the primary goal of 
therapy was movement quality and not game performance. The 
average duration of each swing for each trial was measured in 
seconds.
Data analysis
EMG Preprocessing
Electromyography signals were DC removed, root mean square 
processed using a sliding 50  ms window and demeaned using 
Spike2 software (CED, UK). Mean baseline EMG was measured 
over 1 s prior to the beginning of the Wii-baseball game, while 
the muscles were at rest. The mean was subtracted from the 
signal of the same game for each patient. To enable comparison 
between patients, the EMG of each muscle was normalized to its 
peak amplitude, then averaged over 10 consecutive Wii-baseball 
swings for each patient at early and late therapy and at 6-month 
follow-up.
Non-Negative Matrix Factorization
Muscle synergies were extracted from the EMG signals using 
the NMF method (4, 35, 48, 49). This optimization method 
was applied to the EMG recordings of the six muscles using 
the in-built nnmf function in MATLAB R2014a (MathWorks, 
USA). Random initial values were generated as the input for the 
multiplicative algorithm of the function, the output of which 
provided the initial values of the alternating least squares (ALS) 
algorithm (50). Then, the ALS algorithm was used to characterize 
the EMG of the six recorded muscles (m =  6) as a lower-rank 
combination of the relative weighting (W) of each muscle and the 
timing profile (H) of each synergy (equation below) in a complex 
movement (see Figure 1).
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Number of Muscle Synergies
The number of muscle synergies needed to define coordinated 
muscle activation in a complex movement was determined using 
the term variability accounted for (VAF) (14, 17) and the mean 
squared error (MSE) term (9, 51) according to the formula below. 
The VAF is defined as 100 times the squared correlation coefficient 
between the original EMG (EMGo) and the reconstructed EMG 
(EMGr) from the NMF algorithm (23). The minimum number 
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Similarity of Synergy Timing Profiles
The similarity between individual synergy timing profiles from 
each subject on a group basis was quantified using the scalar 
product (1, 31). More than 50% of patients used four distinct 
synergies to account for the variability of muscle activation at 
early and late therapy and at 6-month follow-up. The analysis of 
similarity between timing profiles requires the same number of 
synergies from each patient to be entered in the analysis to enable 
the comparison of synergy profiles. Thus, regardless of the actual 
number of synergies, four synergies were extracted from the 
muscle activation of all patients. Then, one set of four synergies 
from one subject was randomly selected in each motor-function 
group and used as the template. The synergy timing profiles from 
all other subjects within the same motor-function group at each 
time point were matched to provide the highest scalar product 
between two synergies. The scalar product (r-value) is a measure 
of the similarity in which one numerical vector is projected onto 
another, so that an r-value of 1 represents complete similarity and 
a value of 0 represents the absence of any similarity.
FigUre 1 | Single patient electromyography (EMG) data showing the progression through analysis using non-negative matrix factorization (NMF). The 61-year-old 
male patient with moderate motor-function was 5 months poststroke. (a) Preprocessed normalized EMG from six upper body muscles on the more-affected side 
during Wii-baseball swings prior to processing by the NMF algorithm. (B) Reconstructed EMG after processing by NMF as the integration of muscle synergies for 
each muscle. (c) Each derived muscle synergy is a combination of the timing profile and muscle weightings. FDI, first dorsal interosseous; ECR, extensor carpi 
radialis; FCR, flexor carpi radialis; BB, biceps brachii; DM, deltoid medius; trap, trapezius (middle portion).
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Clustering Synergy Structures
The muscle weightings of the actual synergies from all subjects 
were pooled to be categorized using cluster analysis (23, 51) 
at early and late therapy. This procedure was performed using 
the in-built functions from the MATLAB statistics toolbox. 
Euclidean distance was used to measure the similarity between 
pairs of muscle weightings. The minimum number of clusters 
was determined based on grouping synergies when there was no 
more than one synergy from a subject in each cluster. Cluster 
analysis requires the inclusion of all extracted synergies to avoid 
overlap and to merge the analysis to a limited and realistic num-
ber of clusters. This method avoids the inclusion of more than one 
synergy from each patient in each cluster.
statistical analysis
A potential relationship between the number of muscle synergies 
and the level of motor-function was investigated using Pearson 
chi-square test, Fisher’s exact test, and linear-by-linear associa-
tion. If more than 20% of the cells had an expected count <5, the 
p-value of Fisher’s exact test was reported instead of Pearson 
chi-square. In addition, linear-by-linear association was used to 
reveal trends in larger than 2 × 2 tables. The same tests were used 
after the cluster analysis to evaluate the incidence of each cluster 
in each level of motor-function.
A mixed-effect model was implemented for any given number 
of synergies (range 1–5) to detect the effect of motor-function 
level (low, moderate, high) and time (early therapy, late therapy, 
FigUre 2 | Number of synergies required to define Wii-baseball swing. (a) Comparison of the number of synergies used for patients (n = 24) with different levels of 
motor-function at early and late therapy and for a subset (n = 13) at 6-month follow-up. (B) The number of synergies for all patients (n = 24) at early and late therapy 
(mean ± SE). At early therapy, there was a significant difference between patients with low and high motor-function. There was also a trend toward an increase in the 
number of synergies from early to late therapy for patients with low and moderate motor-function. (c) The number of synergies for the subset of patients (n = 13; 3 
low, 5 moderate, and 5 high motor-function) who completed 6-month follow-up assessments (mean ± SE). There was no significant change over time.
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follow-up) on VAF. This model is powerful and flexible with 
missing data (i.e., to account for n = 13 at follow-up). Clinical 
assessments and game performance data were analyzed using 
paired t-test (for parametric data) and Wilcoxon signed-rank 
test (for non-parametric data) to compare means between time 
points. Statistical analyses were conducted in SPSS 23 software 
(IBM, USA) and the differences were considered significant when 
p < 0.05.
resUlTs
number of synergies extracted  
from Wii-baseball
Difference in the Number of Synergies across Groups
The number of muscle synergies required to define the Wii-
baseball movement is presented in Figure 2A for each level of 
motor-function at each time point. At early therapy, most patients 
with low motor-function used three synergies, while most patients 
with moderate and high motor-function used four synergies to 
define the movement. However, two patients with high motor-
function used five synergies. As can be seen in Figure 2B at early 
therapy, the number of synergies (mean ± SE) for patients with 
low motor-function (3.38 ± 0.18) was significantly less than for 
patients with high motor-function (4.00 ± 0.27) (p = 0.036). At 
early therapy, Fisher’s exact test showed no relationship between 
the number of muscle synergies and the level of motor-function 
(p  =  0.217), although linear-by-linear association indicated a 
trend (p = 0.045).
Changes in the Number of Synergies over Time
At late therapy, an increase in the number of synergies was evi-
dent for patients with low and moderate motor-function, albeit 
not statistically significant (Figure 2B). The number of synergies 
(mean ± SE) increased from 3.38 ± 0.18 to 3.63 ± 0.18 (p = 0.317) 
for patients with low motor-function and from 3.75 ±  0.16 to 
3.88 ± 0.23 (p = 0.564) for patients with moderate motor-function 
from early to late therapy. There was no change for patients with 
high motor-function. For the subset of patients with 6-month 
follow-up data, the number of synergies over time is illustrated 
in Figure 2C. There were no significant changes over time for this 
subset of patients.
consistency of synergy Timing Profiles 
within groups
The synergy timing profiles (Figure 3) were similar for patients 
in each level of motor-function. The timing profile of muscle 
synergies in each group was matched based on the scalar product 
FigUre 4 | Variability accounted for (VAF) in muscle synergies. VAF changed 
little over time; the mean VAF was measured for any given number of 
synergies and compared between patients for the three levels of motor-
function. For each number of synergies, patients with low motor-function had 
higher VAF compared to the other two groups (p < 0.05). Lower VAF for 
patients with moderate and high motor-function indicated that the analysis is 
less able to account for variability of muscle activation because of more 
movement complexity.
FigUre 3 | Synergy activation timing for patients according to the level of residual voluntary motor-function. Thin gray lines illustrate the synergy timing profile for 
each patient (mean of 10 trials), overlaid by the within-group mean (black line). Similar synergies are overlaid based on the scalar product between synergies. The 
r-value shown for each synergy indicates the group-averaged scalar product. For patients with low motor-function, the scalar product between mean synergy 1 and 
2 indicated similarity (r = 0.71). These two synergies were assumed to be one (as indicated by the overlaid box). Thus, patients with low motor-function used three 
distinct synergies to define the movement, while patients with moderate and high motor-function required four synergies.
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(r-value) between pairs of synergies from different patients in 
each group. The within-group mean r-value is shown for each 
synergy in Figure  3. Four distinct synergies demonstrated the 
profile of muscle synergies for patients with high and moder-
ate motor-function. For patients with low motor-function, the 
between-synergy scalar product for synergy 1 and 2 (r = 0.71) 
showed high similarity, suggesting a single synergy. Thus, three 
distinct synergies defined the movement in patients with low 
motor-function.
Variability (VaF) of Muscle synergies 
across groups
Variability accounted for increased with a higher number of syn-
ergies (Figure 4). A mixed-effect model revealed changes in VAF 
according to the level of motor-function over time for any given 
number of muscle synergies (range 1–5) for each patient. The 
level of motor-function, but not the time point, had an effect on 
the VAF (for any given number of synergies p < 0.05); although 
the VAF appears similar between groups in Figure 4, the vari-
ability within each group was large.
Muscle synergy clusters
At early- and late-therapy, the muscle weightings of each synergy 
from all patients were pooled and then categorized into 10 and 
11 clusters, respectively. Thus, all the synergy structures from 
all patients can be summarized into 10 or 11 distinct synergies 
(Figure 5). At early therapy, there was no significant difference in 
the incidence of muscle synergies from different levels of patient 
motor-function in each cluster based on Fisher’s exact test, except 
for cluster 2 (Figure 6). However, a trend was observed in the 
incidence of cluster 3 and 9 using linear-by-linear association 
(see Figure 6).
FigUre 5 | Composition of muscle synergies at early and late therapy. Synergy muscle weightings at early and late therapy were categorized into 10 and 11 
clusters, respectively. For each cluster, the distribution of muscle weightings from different synergies is shown, overlaid by the group mean. The synergy clusters 
changed from early to late therapy except for the first four clusters.
FigUre 6 | Incidence of muscle synergy clusters across groups at early 
therapy. The incidence of muscle synergies did not differ with the level of 
motor-function except for cluster 2 (p < 0.01). There was a trend between 
the incidence of muscle synergies and the level of motor-function in  
clusters 3 and 9 (p < 0.05).
7
Hesam-Shariati et al. Changes in Poststroke Muscle Synergies
Frontiers in Neurology | www.frontiersin.org July 2017 | Volume 8 | Article 277
Wii-baseball game Performance
The number of balls hit by patients was averaged for each record-
ing session. The number of Wii-baseball hits increased (p < 0.001) 
from early therapy (4.42 ±  0.63) to late therapy (7.37 ±  0.40) 
and was sustained at 6-month follow-up (6.33 ± 0.65, p = 0.106). 
There was no difference in the duration of the Wii-baseball swing 
between groups (low, 1.30 ±  0.51  s; moderate, 1.37 ±  0.24  s; 
high, 0.75 ± 0.15 s; p = 0.379), i.e., there was no effect of motor-
function level.
clinical Motor-Function assessments
The clinical motor-function measures showed significant 
improvements from pre- to post-therapy. WMFT task times for 
the pooled data reduced (improved) from 38.1 ± 7.8 to 33.6 ± 7.2 s 
(p = 0.004), FMA scores increased from 46.6 ± 3.6 to 48.9 ± 3.6 
(p  =  0.001), and MALQOM scores of 60.1  ±  8.7 increased 
to 91.3 ±  8.1 (p <  0.001). All improvements were sustained at 
6-month follow-up so that changes from post-therapy to the 
follow-up assessments were not significant (WMFT, p = 0.917; 
FMA, p = 0.107; MALQOM, p = 0.454).
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DiscUssiOn
In this longitudinal study, we identified and quantified muscle 
synergies during formal therapy sessions for patients with 
chronic stroke and different levels of motor-function at early and 
late therapy, and for a subset of patients at 6-month follow-up. 
As far as we can ascertain, this is the first study to investigate 
changes in the coordinated activation of muscles in chronic 
stroke during rehabilitation activities, rather than during 
unrelated clinical assessment tasks or restricted experimental 
tasks. The novel aspects of this study include a broad spectrum 
of poststroke residual voluntary motor-function; and the nature 
of the complex movement that was largely unconstrained, i.e., 
the start and end points were not experimentally predetermined. 
Therapist-guided quality of movement was the primary objec-
tive of the task during which EMG was recorded, and not the 
recording per se or game performance. Despite this, we identified 
differences in the number of muscle synergies used by patients 
as a function of the level of motor deficit. Thus, the profile of 
coordinated muscle activation varied by the level of residual 
motor-function in chronic stroke.
There is abundant evidence in the literature that motor ability 
is stable in the poststroke chronic period (52–54), even in the 
presence of some therapy protocols (55). It is also clear that 
targeted therapy can improve motor ability in contrast to control 
groups [(56, 57), see Ref. (58)]. The control groups receiving usual 
care in these studies provide further evidence of the stability of 
motor performance in chronic stroke for patients not receiving 
therapy or receiving usual care. In our setting, stable motor per-
formance was established using pre-baseline to baseline testing in 
a randomized controlled study comparing WMT and modified 
Constraint-induced Movement Therapy (38).
The statistical outcomes in this study underestimate the level 
of information provided by this complex series of analyses and 
reflect the absence of a consistent pattern of change for between-
patient EMG as identified in Hasam-Shariati et  al. (Paper 1). 
The number of synergies used during Wii-baseball increased 
(although not significantly) with therapy for patients with low 
and moderate motor-function. At early therapy, there was a trend 
between the number of synergies and the level of motor-function 
that suggests different patterns of coordinated muscle activation 
between motor-function groups. The VAF of muscle synergies 
increased with a higher number of synergies, since the muscle 
activation can be defined more accurately with more synergies 
(i.e., smaller error) (17). VAF changed significantly with the level 
of motor-function but not over time within a level. Clustering 
the synergies from all patients showed that the incidence of three 
clusters has an association with the level of motor-function. 
Cluster analyses provide a means of demonstrating changes in the 
muscle weighting of some synergies between control and stroke 
groups (51). This suggests the distribution of muscle weightings 
within synergies in the present study changed as a consequence 
of therapy, as most synergy clusters changed from early to late 
therapy.
The similarity of muscle synergies has been investigated 
differently across studies. For example, the similarity of muscle 
weightings was used to demonstrate patients with different levels 
of motor ability used the same muscles during an isometric 
force generation task (51); whereas the timing profile was used 
to reveal different numbers of muscle synergies according to the 
level of motor ability during gait cycle (17). Our results reflect 
those of Clark et al. (17), in that the similarity of synergy timing 
profiles was used to distinguish the difference in the number of 
muscle synergies between groups: three distinct synergies defined 
the movement for patients with low motor-function, while four 
synergies were required for patients with moderate and high 
motor-function.
The coordination necessary to define a complex movement 
was associated with the level of residual voluntary motor-func-
tion but not the duration of the swing, with differences across 
time points not as evident as those shown in EMG analysis 
(42). This was confirmed by video recordings showing less 
complexity and more muscle co-activation for patients with 
low motor-function. Yet despite significant improvements 
in clinical assessments and Wii-baseball game performance, 
there was no difference in the number of muscle synergies 
over time. However, the change in the structure of muscle 
weightings from the cluster analysis at early and late therapy 
indicates that muscle recruitment changed between time points 
and that there was more diversity in muscle synergies after 
therapy.
Typically, muscle synergies for stroke patients are derived from 
stereotypical (1, 17) or experimentally constrained (30, 51) tasks. 
However, in this study, the movement was largely unconstrained. 
Although this may have reduced the sensitivity of the analysis, it 
is a better reflection of task-related real-world use of the upper 
limb after stroke. This approach also provides a more direct 
assessment of the neurophysiological changes induced by therapy 
(59). Stroke patients with different levels of motor-function use 
different strategies to resolve the same problem (task) (60). As 
highlighted by Hesam-Shariati et al. (42), the muscle characteris-
tics for each patient differ depending on various neuromuscular 
limitations including weakness, hypertonicity, and spasticity. 
Such differences alter the goals of therapy (38) and result in more 
deliberate movement patterns than are seen in healthy control 
subjects (39).
The movement analyzed in this study was performed as 
part of a structured therapy program (61) with no attempt at 
standardization as would occur under experimental conditions 
(7, 51). Due to the range of motor impairment of the patients 
involved in this study, there were no standardized requirements 
for specific joint involvement or movement. The aim of this 
movement during therapy was to increase movement excur-
sion (range of motion), velocity, strength, and control based on 
the generalized movement parameters of a baseball swing by a 
healthy subject. Although little attention was paid to the rules of 
the game, those for Wii-baseball provided some consistency in the 
patient striking response, in that the ball must be pitched (by the 
device) within a relatively small area (62). Thus, the onset of 
movement was determined through the delivery of the ball 
by the device. When the patient mistimed the movement and 
did not hit the ball but completed a swing, this movement was 
included in the analysis. While the start point of the move-
ment was in an unrestricted task-dependant spatiotemporal 
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framework, the end point, duration, speed, and direction were 
unconstrained a priori (38, 40).
The muscles contributing to a synergy varied from patient 
to patient and between patients within each level of motor-
function. Synergy analysis provides a means of examining changes 
in motor coordination after stroke independent of the movement 
strategy of each patient (63). Our previous paper (42) focused 
on the dominant muscle activated during each activity. Here, 
synergy analyses provide a means of understanding how the brain 
coordinates neuromuscular control of movement (64) that can 
be used to build a dynamic model of the poststroke rehabilitation 
process.
Clearly, more than six muscles are necessary to produce the 
movement studied, even poststroke. We were limited in the 
number of channels available by the recording system and have 
previously reported EMG of tibialis anterior (59). The upper 
body muscles in this study were selected for two main reasons. 
First, they included a distribution along the neuromuscular 
axis of the more-affected side. Second, this recording montage 
limits the potential for EMG cross talk (65) while still reflecting 
the major muscle groups involved in the movement across the 
patient cohort (62). We incorporated EMG from the trapezius 
muscle in this analysis as a surrogate marker for trunk rota-
tion where biceps and deltoid activation were insufficient to 
generate sufficient swing movements in Wii-baseball. EMG 
data from FDI were included to reflect the use of the hand 
during therapy because this muscle is readily accessible during 
therapy and was taken as a surrogate marker of intrinsic hand 
muscle activity. FDI activation was task dependant during Wii-
baseball. EMG from triceps brachii was not recorded due to 
technical limitations including its very low level of activation 
compared to BB (66) and problems with loose skin in older 
patients which when combined with gravity acted to pull 
the sensor away from the muscle, rendering such recordings 
unreliable.
Synergy analysis addresses coordinated muscle activation 
(between muscles) rather than activation within each muscle. It 
is impossible after stroke to assume any similarity of underlying 
physiology and anatomy or to individually record the activity 
of each motor unit contributing to compound muscle activity. 
Any recording of EMG or method of EMG analysis will provide 
a biased estimate of activity (67, 68). The number of simultaneous 
recordings will not reduce the bias; in our experience, it increases 
the potential for cross talk and phase cancelation. Given the 
variability of impairment and ability after stroke both in the neu-
romusculature and factors impinging on the neuromusculature 
(e.g., somatosensation), in addition to the trial to trial variability 
for any given patient, it would be extremely difficult to estimate 
the ideal number of channels necessary for error-free synergy 
analyses.
clinical implications
This study addresses the paucity of neurophysiological stud-
ies after stroke and as a consequence of therapy. This lon-
gitudinal investigation of changes in muscle synergies with 
therapy in chronic stroke across patients with different levels of 
motor-function provides initial insights into some of the 
neurophysiological mechanisms underpinning a therapy that 
is the equivalent of current best practice poststroke, namely, 
Constraint-induced Movement Therapy (38). Although there 
were few changes in the number of synergies, the altered structure 
of muscle synergies suggest that the coordination of muscle acti-
vation did improve and that this change was reflected in improved 
clinical assessment data (28) [presented in detail in Hesam-
Shariati et al. (42)]. In particular, the significant improvements 
in MALQOM scores reflect greater independence in activities of 
everyday living (38).
This study demonstrates that the number of synergies, synergy 
timing profiles, distribution of muscle weightings, and VAF for 
muscle synergies differ according to the level of motor-function; 
particularly for patients with low motor-function at early therapy. 
These differences provide more detailed information about the 
neurophysiological functioning after stroke and how this changes 
with therapy. We hypothesize that altered muscle synergy struc-
ture reflects changes in brain connectivity, but this requires spe-
cific investigations of brain imaging or brain stimulation (69, 70). 
Nevertheless, the structure of muscle synergies can be used as an 
approach to classify stroke patients and to inform rehabilitation 
methods. However, muscle synergy analyses are insufficient on 
their own to fully understand neurophysiological changes with 
therapy after stroke and these analyses further emphasize the 
absence of any one tool to adequately quantify and explain the 
changes after stroke or with rehabilitation.
study limitations
The primary focus of WMT is on the quality of move-
ment, and increasing independent use of the more- 
affected upper limb in everyday tasks (38, 39). For this reason, 
therapy instructions are not those that would be used with healthy 
control subjects. For example, the different phases of the move-
ment are emphasized differently depending on the level of motor 
impairment and may be practiced individually before being 
combined during the game performance using the principles of 
shaping (71), much like a sporting drill. Although the absence of 
healthy control subjects is a limitation of this study, the different 
movement patterns observed during game play (39) may limit 
the usefulness of such comparisons.
The sample size in this study is small within each level of 
motor-function. However, the total number of patients compares 
well with previous stroke studies investigating muscle synergies 
(18, 23, 30, 51). According to clinical assessment scores, this 
cohort included a wide range of residual voluntary motor capac-
ity, particularly those with low motor-function who are rarely 
recruited in poststroke therapy and neurophysiology studies. 
This approach reduces the potential for statistically significant 
outcomes when data are pooled (59) but provides data that can 
be more readily generalized to the stroke population, although 
this study in chronic stroke cannot be generalized to the acute 
and subacute phase.
cOnclUsiOn
Motor control differs for patients with different levels of residual 
voluntary motor-function when performing the same movement. 
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Despite this, muscle synergies can be identified and monitored 
during therapy to understand changes in motor control of a 
largely unconstrained complex movement. A higher number 
of muscle synergies reflects greater movement complexity and 
task-related phasic muscle activation. This result is evidence for 
less complexity and more co-activation in the patterns of muscle 
activation for patients with low motor-function. The increased 
number of synergies by late therapy suggests improved motor 
control with more distinct phases of movement for patients with 
low motor-function. The change in the muscle synergy clusters 
by late therapy and different patterns of recovery indicate that 
the recruitment and activation of muscles change during therapy.
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